查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945156

無菌液體處理袋市場按材料類型、容量、應用、最終用戶和分銷管道分類，全球預測（2026-2032年）

Sterile Liquid Handling Bag Market by Material Type, Capacity, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

無菌液體處理袋市場預計到 2025 年將達到 15.1 億美元，到 2026 年將成長到 17.1 億美元，到 2032 年將達到 39.6 億美元，複合年成長率為 14.77%。

主要市場統計數據
基準年 2025 15.1億美元
預計年份：2026年 17.1億美元
預測年份：2032年 39.6億美元
複合年成長率 (%) 14.77%

策略實施旨在明確無菌液體處理袋在臨床工作流程、供應鏈、法規環境和創新中的作用。

無菌液體處理袋已從簡單的容器產品發展成為臨床護理、實驗室工作流程和生物製程操作的核心組件。本導言概述了這些一次性系統如何與病人安全、供應鏈連續性和技術驅動的工作流程相聯繫，並建立了貫穿本研究的分析框架。

擁抱變革，透過創新材料、數位化、精實生產和不斷發展的臨床工作流程，重新定義無菌液體處理袋。

無菌液體處理袋領域正經歷一場變革，這主要得益於材料科學、製造自動化和數位化整合技術的同步發展。材料創新，特別是從傳統PVC配方轉變為非PVC結構的轉變，解決了人們對塑化劑、萃取物以及與現代無菌和儲存條件相容性的擔憂。伴隨材料變革而來的是生產技術的進步，使得製造更薄、多層、具有客製化阻隔性能和機械耐久性的薄膜成為可能。

評估2025年美國關稅及其對無菌液體處理袋的採購、供應鏈韌性、監管負擔和國際貿易的影響

2025年美國關稅政策為無菌液體處理袋的製造商、經銷商和終端用戶帶來了新的挑戰。在生產層面，進口聚合物、薄膜基材或成品組件的關稅將增加投入成本，並可能改變採購決策。許多製造商正在透過重新評估供應商關係、盡可能增加近岸或國內採購以及談判長期合約來應對這些挑戰，以穩定供應並應對價格波動。

細分市場洞察揭示了材料、應用、終端用戶環境、銷售範圍和分銷管道如何影響產品優先順序和商業性重點。

市場區隔旨在識別需求領域以及創新能夠創造最大商業性價值的領域。從材料角度來看，市場分為非PVC結構和PVC結構，非PVC結構進一步細分為多層設計以及聚乙烯和聚丙烯等不同類型。這些材料選擇反映了對阻隔性能、化學相容性和法規遵循的優先考慮。應用細分涵蓋血液採集、細胞培養、引流、輸液和清潔，每種應用場景對連接器類型、生物相容性和無菌操作方法都有獨特的要求。

區域分析比較了美洲、歐洲、中東、非洲和亞太地區的需求促進因素、法規環境、生產能力和招聘趨勢。

區域趨勢對產品設計、監管策略和商業性執行有顯著影響。在美洲，採購往往傾向於那些既能遵守監管規定又能提供靈活物流的供應商，而創新則是由大型醫療保健系統和不斷擴展的專業製造地網路共同驅動的。法規環境強調基於風險的評估和上市後監測，對於業務遍及多個州的供應商而言，可追溯性和無菌保證的重要性日益凸顯。

關鍵公司層面洞察，重點在於領先供應商的競爭考察、創新重點、夥伴關係策略、垂直整合措施和差異化策略

企業層面的發展趨勢著重於透過材料創新、生產規模化和策略聯盟實現供應商差異化。主要企業正投入研發資源，以減少可萃取物、擴大無PVC薄膜的使用，並設計兼顧柔軟性和阻隔保護的多層結構。同時，契約製造製造商也在擴大產能，以滿足品牌所有者在保證品質和合規性的同時外包生產的需求。

為產業領導者提供切實可行的策略建議，以加速產品創新、最佳化採購、加強合規性並擴大臨床應用。

行業領導者應採取一系列措施，在降低供應和監管風險的同時創造價值。首先，應加快材料多樣化，在臨床適用的情況下，對非PVC多層材料、PE和PP結構進行認證，同時保持合格的萃取物和相容性測試，以滿足醫療專業人員的期望。這將減少對單一樹脂的依賴，並使產品供應與永續性和安全性優先事項保持一致。

一種透明的調查方法，結合了關鍵相關人員訪談、供應商分析、技術檢驗和多源資料三角測量。

本調查方法結合了結構化的初步研究和嚴謹的二次檢驗技術分析。初步資料收集包括對採購主管、臨床終端使用者、監管專家和生產主管的訪談，以了解實際挑戰、採購標準和創新重點。訪談結果用於建構生態系統圖，識別各區域的關鍵供應商、契約製造製造商和分銷合作夥伴。

對推動無菌液體處理袋創新和應用的相關人員的策略重點、核心風險和機會管道進行權威的綜合分析。

分析表明，無菌液體處理袋領域正處於材料科學創新、供應鏈實際應對措施和不斷變化的臨床需求三者交匯點。相關人員將更有利於抓住市場機遇，而相關人員投資於健全的採購系統和數位化可追溯性的利益相關者則能夠降低貿易中斷和品質風險。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 依材料類型分類的無菌液體處理袋市場

  • 不含聚氯乙烯
    • 多層結構
    • PE
    • PP
  • PVC

9. 無菌液體處理袋市場（以銷售量計）

  • 500～1,000ml
  • 500毫升或以下
  • 超過1000毫升

第10章 無菌液體處理袋市場按應用領域分類

  • 血液收集
  • 細胞培養
  • 引流
  • 點滴
  • 打掃

第11章 無菌液體處理袋市場（依最終用戶分類）

  • 門診手術中心
  • 診所
  • 醫院
  • 研究所

第12章 無菌液體處理袋市場（依通路分類）

  • 離線
  • 線上

第13章 無菌液體處理袋市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 無菌液體處理袋市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國無菌液體處理袋市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國無菌液體處理袋市場

第17章：中國無菌液體處理袋市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ABEC Inc
  • Agilent Technologies Inc
  • Avantor Inc
  • B. Braun Melsungen AG
  • Baxter International Inc
  • Becton Dickinson and Company
  • Corning Incorporated
  • Danaher Corporation
  • Entegris Inc
  • Eppendorf SE
  • Fresenius Kabi AG
  • Fujimori Kogyo Co Ltd
  • GEA Group AG
  • Gilson Inc
  • Grifols SA
  • Hamilton Company
  • ICU Medical Inc
  • Lonza Group AG
  • Meissner Filtration Products Inc
  • Merck KGaA
  • Nipro Corporation
  • Poly Medicure Limited
  • Repligen Corporation
  • Saint-Gobain
  • Sartorius AG
  • Single Use Support GmbH
  • Tecan Group Ltd
  • Terumo Corporation
  • Thermo Fisher Scientific Inc
  • VWR International LLC
Product Code: MRR-3F575F195241

The Sterile Liquid Handling Bag Market was valued at USD 1.51 billion in 2025 and is projected to grow to USD 1.71 billion in 2026, with a CAGR of 14.77%, reaching USD 3.96 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.51 billion
Estimated Year [2026] USD 1.71 billion
Forecast Year [2032] USD 3.96 billion
CAGR (%) 14.77%

A strategic introduction framing the role of sterile liquid handling bags across clinical workflows, supply chains, regulatory conditions, and innovation

The sterile liquid handling bag has evolved from a simple containment product into a pivotal component across clinical care, laboratory workflows, and bioprocessing operations. This introduction outlines how these disposable systems intersect with patient safety, supply-chain continuity, and technology-enabled workflows while establishing the analytical framework used throughout the study.

Sterility, material compatibility, and ease of handling are core attributes that define the product class, but their importance is amplified by contemporaneous demands: tighter regulatory expectations, rising preference for single-use technologies in infection control, and clinical teams seeking reliable, ergonomically designed consumables. In parallel, manufacturers face pressures to innovate on materials and manufacturing processes to reduce extractables, improve barrier properties, and deliver consistent performance under sterilization.

The following analysis situates these technical and commercial dynamics within the broader ecosystem of clinicians, procurement professionals, contract manufacturers, and distributors. By clarifying the intersections among materials science, clinical needs, and supply continuity, this introduction primes decision-makers to understand the strategic levers that will shape future product development and market positioning.

Capturing transformative shifts redefining sterile liquid handling bags through novel materials, digitalization, lean manufacturing and evolving clinical workflows

The sterile liquid handling bag landscape is experiencing catalytic shifts driven by simultaneous advances in material science, manufacturing automation, and digital integration. Materials innovation-particularly the pivot from legacy PVC formulations to non-PVC constructions-addresses concerns about plasticizers, extractables, and compatibility with modern sterilization and storage regimes. This materials evolution is accompanied by production technologies that enable thinner, multi-layer films with tailored barrier properties and improved mechanical resilience.

Concurrently, digital technologies are being embedded across manufacturing and supply chains to improve traceability, lot-level visibility, and quality control. Smart labeling, enhanced serialization, and integration with electronic inventory systems reduce the risk of counterfeits, enable faster recall management, and support clinical workflows that demand real-time stock data. Manufacturing-level automation and continuous-production approaches compress lead times and increase consistency, which is particularly valuable where single-use components are subject to rigorous sterility requirements.

Finally, clinical demand patterns are shifting: heightened focus on infection prevention, adoption of single-use bioprocessing in research and production, and the need for flexible fluid management solutions in ambulatory and decentralized care settings. Together, these transformative forces are reshaping product roadmaps, procurement strategies, and partnership models across the value chain.

Assessing United States tariffs in 2025 and their effects on sterile liquid handling bag sourcing, supply chain resilience, regulatory burden, and global trade

United States tariff actions in 2025 have introduced a new layer of complexity for manufacturers, distributors, and end users of sterile liquid handling bags. At the production level, tariffs on imported polymers, film substrates, or finished components can increase input costs and alter sourcing decisions. Many manufacturers respond by reassessing supplier relationships, expanding nearshore or domestic sourcing where feasible, and negotiating long-term agreements that stabilize supply and price volatility.

Tariff-driven cost pressures ripple through procurement and clinical channels. Health systems and research institutions may encounter higher unit prices or reconfigured purchasing agreements, prompting procurement teams to re-evaluate total cost of ownership, vendor consolidation strategies, and inventory policies. In some cases, buyers will prioritize suppliers with localized production or vertically integrated operations that can shield them from cross-border tariff exposure.

Regulatory and compliance activities intersect with tariff impacts. Changes to supply chains often necessitate additional validation, updated supplier audits, and revised documentation to ensure materials and sterilization processes remain compliant with applicable standards. For organizations that rely on just-in-time inventories, tariffs can amplify the importance of contingency planning and risk mitigation, encouraging investments in buffer stocks, alternate suppliers, and collaborative forecasting with strategic partners.

In the aggregate, tariffs are accelerating supply-chain diversification, incentivizing investment in domestic capabilities, and elevating the strategic importance of procurement resilience and regulatory agility across the sterile liquid handling bag ecosystem.

Segmentation insights showing how materials, applications, end-user settings, capacity ranges and channels shape product priorities and commercial focus

Segmentation clarifies where demand concentrates and where innovation can deliver the most commercial value. From a materials perspective, the market differentiates between Non-PVC and PVC constructions, with Non-PVC further subdivided into multi-layer designs as well as polyethylene and polypropylene variants; the choice among these materials reflects priorities around barrier performance, chemical compatibility, and regulatory acceptability. Application segmentation spans blood collection, cell culture, drainage, infusion, and irrigation, each use case imposing distinct requirements for connector types, biocompatibility, and sterilization methods.

End-user segmentation differentiates ambulatory surgical centers, clinics, hospitals, and research laboratories, with procurement strategies and clinical handling practices varying substantially across these settings. Capacity segmentation includes small-volume offerings under 500 mL, mid-range 500-1000 mL formats, and larger bags exceeding 1000 mL; capacity decisions are driven by clinical protocols, storage constraints, and single-use versus batch-processing modalities. Distribution channels encompass direct sales relationships, third-party distributors, online procurement platforms, and retail pharmacies, all of which shape pricing structures, lead times, and service expectations.

Understanding the interplay among material choices, application needs, user environments, capacity preferences, and distribution pathways allows suppliers to prioritize formulation R&D, tailor commercial models, and design packaging and labeling that reduce adoption friction in target segments.

Regional insights that compare demand drivers, regulatory environments, production capacity, and adoption trends across the Americas, EMEA, and Asia-Pacific

Regional dynamics materially influence product design, regulatory strategy, and commercial execution. In the Americas, procurement tends to favor suppliers that combine regulatory compliance with responsive logistics, while innovation is driven by a mix of large health systems and a growing network of specialty biomanufacturing sites. The regulatory environment emphasizes risk-based evaluation and post-market surveillance, which elevates the importance of traceability and sterility assurance for suppliers operating across multiple states.

Europe, the Middle East & Africa (EMEA) presents a heterogeneous regulatory landscape where harmonization efforts coexist with country-level variances; suppliers must navigate regional device regulations, stringent environmental standards, and an increased focus on sustainability that influences material selection and end-of-life considerations. Distribution models in EMEA often hinge on established distributor networks and tender processes that reward proven clinical performance and regulatory clarity.

Asia-Pacific demonstrates fast-paced capacity expansion, with several markets prioritizing domestic manufacturing and scale-up to support local healthcare infrastructure and export ambitions. Adoption in the region is propelled by investments in ambulatory care and laboratory facilities, but suppliers must adapt to diverse reimbursement frameworks and varying regulatory pathways. Across all regions, strategic decisions around manufacturing footprint, regulatory submissions, and commercial partnerships are central to maximizing reach and minimizing supply disruption.

Key company-level insights highlighting competitive dynamics, innovation priorities, partnership strategies, vertical integration moves, and differentiation tactics among leading suppliers

Company-level dynamics center on how suppliers differentiate through material innovation, manufacturing scale, and strategic partnerships. Leading manufacturers are allocating R&D resources to reduce extractables, broaden the use of non-PVC films, and engineer multi-layer constructions that balance flexibility with barrier protection. At the same time, contract manufacturing organizations are expanding capacity to serve brand owners seeking to outsource production while preserving quality and compliance.

Competitive positioning increasingly depends on a combination of vertical integration and collaborative ecosystems. Firms that control polymer supply, film extrusion, bag fabrication, and sterilization can offer shorter lead times and more predictable quality; conversely, companies that excel in rapid innovation often partner with specialized film producers and academic labs to accelerate material qualification. Partnerships with logistics providers, distributors, and clinical training organizations further extend reach and reduce adoption friction in complex health systems.

Mergers, strategic alliances, and selective investments in capacity are common tactics to secure supply, access new geographies, and lock in procurement channels. Companies that emphasize clear regulatory pathways, demonstrable clinical performance, and supply continuity gain trust with institutional buyers and stand a greater chance of securing preferred-supplier arrangements.

Actionable strategic recommendations for industry leaders to accelerate product innovation, optimize sourcing, strengthen compliance, and expand clinical adoption

Industry leaders should adopt a portfolio of actions to capture value while mitigating supply and regulatory risks. First, accelerate materials diversification by qualifying non-PVC multi-layer, PE, and PP constructions where clinically appropriate, while maintaining robust extractables and compatibility testing to meet clinician expectations. Doing so reduces dependency on a single resin stream and aligns product offerings with sustainability and safety priorities.

Second, invest in supply-chain resilience through a blend of nearshoring, strategic dual-sourcing, and capacity agreements with contract manufacturers to mitigate tariff and logistics exposures. Complement those investments with enhanced traceability-serialisation and digital lot tracking-to improve recall responsiveness and satisfy procurement risk assessments. Third, tailor commercial models to end-user needs by offering differentiated packaging and capacity formats for ambulatory surgical centers, clinics, hospitals, and research labs, and by aligning distribution strategies across direct sales, distributors, online channels, and retail pharmacy pathways.

Finally, prioritize regulatory and quality investments that expedite approvals and reduce time-to-adoption. Engage early with regulatory bodies on novel materials and new sterilization regimes, and consider collaborative post-market studies with healthcare partners to demonstrate real-world performance. These actions, taken together, will help organizations convert technical advances into durable commercial advantage.

Transparent research methodology combining primary stakeholder interviews, supplier mapping, technical validation, and multi-source data triangulation

The research methodology combines structured primary engagement with rigorous secondary validation and technical analysis. Primary data collection included interviews with procurement leaders, clinical end users, regulatory specialists, and manufacturing executives to capture real-world challenges, procurement criteria, and innovation priorities. These interviews informed an ecosystem map that identified critical suppliers, contract manufacturers, and distribution partners across geographies.

Secondary research provided context on regulatory frameworks, material science developments, and published device guidance, while laboratory-level technical validation reviewed material compatibility, sterilization performance, and handling ergonomics. Data triangulation reconciled disparate inputs-qualitative interview findings, technical lab results, and supply-chain observations-to ensure consistent conclusions. Quality controls included reviewer cross-checks, replicate interviews where discrepancies emerged, and targeted follow-ups to clarify ambiguous or conflicting evidence.

This layered approach ensures that findings reflect both the operational realities of healthcare delivery and the technical constraints of materials and manufacturing, providing leaders with defensible insights they can act upon.

A conclusive synthesis of strategic priorities, core risks, and opportunity pathways for stakeholders driving sterile liquid handling bag innovation and uptake

The analysis concludes that the sterile liquid handling bag sector sits at the intersection of material science innovation, supply-chain pragmatism, and shifting clinical priorities. Stakeholders who align materials strategy with regulatory expectations and clinical needs will be best positioned to capture adoption opportunities, while those who invest in resilient sourcing and digital traceability will reduce exposure to trade disruptions and quality risk.

Risk vectors to monitor include tariff environments, single-sourced resin dependencies, and evolving sterilization and compatibility standards that could affect product acceptability. Opportunity pathways include targeted R&D into non-PVC multi-layer solutions, expansion into high-growth clinical and research segments, and platform strategies that integrate disposables with digital inventory and quality systems. By synthesizing these priorities into a coherent plan-balancing innovation investment with operational resilience-organizations can translate technical capability into sustained commercial performance.

Decision-makers should prioritize actions that deliver both short-term stability and long-term differentiation, ensuring procurement, regulatory, and R&D teams coordinate around common objectives to accelerate adoption and reduce systemic risk.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sterile Liquid Handling Bag Market, by Material Type

  • 8.1. Non-PVC
    • 8.1.1. Multi-Layer
    • 8.1.2. PE
    • 8.1.3. PP
  • 8.2. PVC

9. Sterile Liquid Handling Bag Market, by Capacity

  • 9.1. 500-1000 Ml
  • 9.2. <500 Ml
  • 9.3. >1000 Ml

10. Sterile Liquid Handling Bag Market, by Application

  • 10.1. Blood Collection
  • 10.2. Cell Culture
  • 10.3. Drainage
  • 10.4. Infusion
  • 10.5. Irrigation

11. Sterile Liquid Handling Bag Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals
  • 11.4. Research Laboratories

12. Sterile Liquid Handling Bag Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Sterile Liquid Handling Bag Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Sterile Liquid Handling Bag Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Sterile Liquid Handling Bag Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Sterile Liquid Handling Bag Market

17. China Sterile Liquid Handling Bag Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ABEC Inc
  • 18.6. Agilent Technologies Inc
  • 18.7. Avantor Inc
  • 18.8. B. Braun Melsungen AG
  • 18.9. Baxter International Inc
  • 18.10. Becton Dickinson and Company
  • 18.11. Corning Incorporated
  • 18.12. Danaher Corporation
  • 18.13. Entegris Inc
  • 18.14. Eppendorf SE
  • 18.15. Fresenius Kabi AG
  • 18.16. Fujimori Kogyo Co Ltd
  • 18.17. GEA Group AG
  • 18.18. Gilson Inc
  • 18.19. Grifols S.A.
  • 18.20. Hamilton Company
  • 18.21. ICU Medical Inc
  • 18.22. Lonza Group AG
  • 18.23. Meissner Filtration Products Inc
  • 18.24. Merck KGaA
  • 18.25. Nipro Corporation
  • 18.26. Poly Medicure Limited
  • 18.27. Repligen Corporation
  • 18.28. Saint-Gobain
  • 18.29. Sartorius AG
  • 18.30. Single Use Support GmbH
  • 18.31. Tecan Group Ltd
  • 18.32. Terumo Corporation
  • 18.33. Thermo Fisher Scientific Inc
  • 18.34. VWR International LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL STERILE LIQUID HANDLING BAG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL STERILE LIQUID HANDLING BAG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY MULTI-LAYER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY MULTI-LAYER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY MULTI-LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY 500-1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY 500-1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY 500-1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY <500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY <500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY <500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY >1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY >1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY >1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY IRRIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY IRRIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY IRRIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 133. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 134. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 154. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 155. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 161. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)